WA

Waters Corporation

WATHealthcareNASDAQ

Diagnostics & Research

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$3.17B
+7.0% YoY
Net Income
$642.6M
+0.8% YoY
EBITDA
$1.03B
-0.6% YoY
Free Cash Flow
-$502.4M

Scan Results

Daily timeframe
2 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Jul 11 MACD Negative CrossoverHistogram -0.3728, negative momentum
Jul 10 MACD Negative CrossoverHistogram -0.3400, negative momentum
About Waters Corporation

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The $36.23B market capitalization puts WAT squarely in large-cap range for its industry. The company operates through two segments, Waters and TA.

Key stats
Market Cap$36.23B
P/E (TTM)48.11
Fwd P/E22.37
EPS$7.67
Beta1.20
52W Change+28.3%
ROE5.2%
Analysis

On the balance sheet, WAT has $462.0M in cash with $5.60B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. The company is burning cash, with free cash flow at -$502.4M. This typically occurs when a company is investing aggressively in growth, but sustained cash burn can strain the balance sheet. Return on equity stands at 5.2%, which is modest for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 3.3% is on the lower side, which is common in asset-heavy industries. Revenue has been relatively flat, moving from $2.97B (2022) to $3.17B (2025).

The debt-to-cash ratio suggests meaningful leverage on the balance sheet, a factor worth monitoring if credit conditions tighten. The company is burning cash at the operating level, which is not unusual for growth-phase companies but adds risk if it persists. No single metric tells the full story. Reviewing WAT's risk profile alongside its fundamentals and technical indicators provides a more complete picture.

Links
More Healthcare stocks
Browse all stocks →
Not financial advice. Scanance is an educational tool. Past performance does not guarantee future results.PrivacyTerms